Anurag Singh

Trials

Studies that name Anurag Singh as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:23 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06884215 · Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

  Amazentis SA · completed · Irritation/Irritant, Sensitisation · study director
• Ph3
  NCT06563388 · Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial

  Roswell Park Cancer Institute · recruiting · Oligometastasis, Lung Cancer, Colo-rectal Cancer · principal investigator
• N/A
  NCT05138900 · A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer

  Roswell Park Cancer Institute · active not recruiting · Non Small Cell Lung Cancer · principal investigator
• N/A
  NCT05079607 · Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

  Amazentis SA · completed · Irritation/Irritant, Sensitisation · study director
• N/A
  NCT04985630 · The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

  Amazentis SA · recruiting · Healthy Aging, Healthy, Healthy Diet · principal investigator
• Ph2
  NCT04682158 · Propranolol With Chemotherapy or Chemoradiation for Esophageal Adenocarcinoma

  Roswell Park Cancer Institute · recruiting · Esophageal Adenocarcinoma · principal investigator
• N/A
  NCT04596254 · Detection of Gut Metabolites in Mother's Milk Following Juice Intake

  Amazentis SA · completed · Healthy Diet · study director
• N/A
  NCT03630601 · Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers

  Roswell Park Cancer Institute · terminated · Breast Carcinoma, Healthy Subject, Malignant Soft Tissue Neoplasm · principal investigator
• Ph2
  NCT03574792 · Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

  Roswell Park Cancer Institute · completed · Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 · principal investigator
• Early Ph1
  NCT03348748 · Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer

  Roswell Park Cancer Institute · terminated · Stage I Non-Small Cell Lung Cancer AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 · principal investigator
• Ph1
  NCT02531906 · Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation

  Roswell Park Cancer Institute · completed · Head and Neck Squamous Cell Carcinoma, Pain, Stomatitis · principal investigator
• N/A
  NCT02474095 · Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer

  Roswell Park Cancer Institute · completed · Head and Neck Carcinoma, Xerostomia · principal investigator
• N/A
  NCT02472340 · Mitophagy and Autophagy in Elderly Subjects

  Amazentis SA · completed · Aging, Frailty, Mitophagy · study director
• N/A
  NCT01896778 · Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

  Roswell Park Cancer Institute · completed · Adult Liver Carcinoma, Breast Carcinoma, Colon Carcinoma · principal investigator
• Early Ph1
  NCT01781741 · Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

  Roswell Park Cancer Institute · completed · Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer · principal investigator
• Ph1
  NCT01728480 · Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

  Roswell Park Cancer Institute · withdrawn · Mucositis, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx · principal investigator
• Ph2
  NCT01682031 · Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy

  Roswell Park Cancer Institute · terminated · Chemotherapeutic Agent Toxicity, Mucositis, Radiation Toxicity · principal investigator
• Ph2
  NCT01674374 · Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy

  Roswell Park Cancer Institute · withdrawn · Mucositis, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Cancer Stress Biology
  P30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2026 · $67,181 awarded in 2026
  Same name and institution; not confirmed by an ID
• Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
  UG1CA233191 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2019 to 2025 · $305,626 awarded in 2025
  Same name and institution; not confirmed by an ID
• Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
  U10CA180866 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · fiscal years 2014 to 2018 · $585,200 awarded in 2018
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Non-invasive assessment of salivary gland function: Translational Studies
  R01CA204636 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Mukund Seshadri · fiscal years 2016 to 2019
  Named on NCT03630601